Study of TB treatment outcomes in people with pulmonary tuberculosis
Part of Infections, Lungs & breathing clinical trials.
This study is collecting information from people who are starting TB treatment to learn more about how well the treatment works. The goal is to better understand factors that influence TB treatment success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with pulmonary tuberculosis (TB) in your lungs
- You plan to start TB treatment
- You give your consent (for adults 18 years or older); for minors, a parent or guardian must give consent
- You do not have another serious illness that makes it hard to track TB treatment outcomes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at your lung health and overall wellbeing after finishing treatment for tuberculosis (TB). It aims to understand how TB affects breathing and quality of life, so doctors can better support recovery.
This study tests different ways to treat active lung TB that is not resistant to rifampicin. It aims to find the best treatment duration and combination to cure TB and prevent it from coming back.
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
This study tracks people with tuberculosis that is mainly outside the lungs (extrapulmonary TB). It collects medical information and samples to better understand the disease and improve care. If you have this type of TB, joining could help advance knowledge and treatment.
This study follows people who are newly treated for tuberculosis, including lung and non-lung (extra-lung) cases. It may help doctors better understand tuberculosis and how patients respond after treatment starts.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.